Persistent Atrial Fibrillation
206
31
52
73
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
37 trials with published results (18%)
Research Maturity
73 completed trials (35% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
5.8%
12 terminated out of 206 trials
85.9%
-0.7% vs benchmark
6%
12 trials in Phase 3/4
51%
37 of 73 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 73 completed trials
Clinical Trials (206)
A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
Feasibility Study of the FARAFLEX Mapping and PFA System
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
The PIFPAF-PFA Study
Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System
STOP Persistent AF PAS
PVI Alone Versus PVI Plus PWI and SVCI With PFA
Endocardial Mapping With the CoreMap EP Mapping System
Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
A Multicenter Feasibility Study With the VERAFEYE Imaging and Guidance System as Anatomical Navigation System
Atrial Remodeling After PFA Substrate Modification for Persistent AF (PeAF)
Acute Responses to Exercise in Females and Males With Symptomatic Atrial Fibrillation
Convergent Ablation Plus Left Atrial Appendage Isolation for the Treatment of Persistent Atrial Fibrillation
SPHERE Per-AF Post-Approval Study
PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II)